Prevalence and risks for bacterial vaginosis in women who have sex with women

Sexually Transmitted Diseases

Volumn 37, Issue 5, 2010, Pages 335-339

  Marrazzo, Jeanne M ^a   Thomas, Katherine K ^a   Agnew, Kathy ^a   Ringwood, Kathleen ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUBRICATING AGENT;

ADOLESCENT; ADULT; ANUS INTERCOURSE; ARTICLE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FEMALE; HIGH RISK BEHAVIOR; HUMAN; INFECTION RISK; LESBIAN; MAJOR CLINICAL STUDY; ORAL SEXUAL CONTACT; PATHOGENESIS; PREVALENCE; SEXUAL BEHAVIOR; VAGINA DISCHARGE; VAGINITIS;

ADOLESCENT; ADULT; FEMALE; HETEROSEXUALITY; HOMOSEXUALITY, FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEXUAL PARTNERS; VAGINA; VAGINAL DOUCHING; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 77951692768     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181ca3cac     Document Type: Article

References (23)

1. Sweet RL. Gynecologic conditions and bacterial vaginosis: Implications for the non-pregnant patient. Infect Dis Obstet Gynecol 2000; 8:184-190.
2. Leitich H, Bodner-Adler B, Brunbauer M, et al. Bacterial vagi-nosis as a risk factor for preterm delivery: A meta-analysis. Am J Obstet Gynecol 2003; 189:139-147.
3. Myer L, Denny L, Telerant R, et al. Bacterial vaginosis and susceptibility to HIV infection in South African women: A nested case-control study. J Infect Dis 2005; 192:1372-1380.
4. Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007; 34:864-869.
5. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
6. Hillier SL, Marrazzo JM, Holmes KK. Bacterial vaginosis. In: Holmes KK, Sparling PF, Mardh PA, et al, eds. Sexually Transmitted Diseases. New York, NY: McGraw-Hill, 2008.
7. Cherpes TL, Hillier SL, Meyn LA, et al. A delicate balance: Risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis 2008; 35:78-83.
8. Marrazzo JM, Koutsky LA, Eschenbach DA, et al. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis 2002; 185:1307-1313.
9. Turner CF, Rogers M, Lindberg LD, et al. Adolescent sexual behavior, drug use, and violence: Increase reporting with computer survey technology. Science 1998; 280:867-873.
10. Kissinger PR, Farley T, Trim S, et al. Application of computer-assisted interviews to sexual behavior research. Am J Epidemiol 1999; 149:950-954.
11. Webb PM, Fortenberry JD, Blythe MJ. Comparability of a computer-assisted versus written method for collecting health behavior information from adolescent patients. J Adolesc Health 1999; 24:383-388.
12. Metzger DS, Koblin B, Turner C, et al; HIVNET Vaccine Preparedness Study Protocol Team. Randomized controlled trial of audio computer-assisted self-interviewing: Utility and acceptability in longitudinal studies. Am J Epidemiol 2000; 152:99-106.
13. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22.
14. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193:1478-1486.
15. Sanchez S, Garcia P, Thomas KK, et al. Intravaginal metronida-zole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: A randomized controlled trial. Am J Obstet Gynecol 2004; 191:1898-1906.
16. Schwebke JR, Desmond R. Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases. Sex Transm Dis 2005; 32:654-658.
17. Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006; 194:1283-1289.
18. Marrazzo JM, Antonio M, Agnew K, et al. Distribution of genital Lactobacillus strains shared by female sex partners. J Infect Dis 2009; 199:680-683.
19. Anderson DJ, Williams DL, Ballagh SA, et al. Safety analysis of the diaphragm in combination with lubricant or acidifying micro-bicide gels: Effects on markers of inflammation and innate immunity in cervicovaginal fluid. Am J Reprod Immunol 2009; 61:121-129.
20. Schwartz JL, Mauck C, Lai JJ, et al. Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: A randomized double-blind Phase I safety study. Contraception 2006; 74:133-140.
21. van der Straten A, Napierala S, Cheng H, et al. A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe. Contraception 2007; 76:389-399.
22. Adriaens E, Remon JP. Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay. Sex Transm Dis 2008; 35:512-516.
23. Bailey JV, Benato R, Owen C, et al. Vulvovaginal candidiasis in women who have sex with women. Sex Transm Dis 2008; 35: 533-536.